Emerald Bioscience Inc. announced the appointment of Alice Chen as Executive Director, Clinical Operations. Ms. Chen has twenty years of global clinical research experience working with early and late-stage biotech companies, particularly in the planning and execution of clinical trials for a variety of indications, including oncology, hepatology, autoimmune, and orphan diseases. Prior to joining Emerald, Ms. Chen served as the Head of Clinical Operations at Zafgen Inc.